Covera-hs
NDC Package 0025-2011-34

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Covera-hs is a . Marketed by Pfizer Laboratories Div Pfizer Inc, this product is identified by NDC 0025-2011 and is authorized under FDA application NDA020552.

Identification & Billing

NDC Package Code
0025-2011-34
Package Description
100 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Product Code
0025-2011
11-Digit Billing Format
00025201134

Clinical Specifications

Proprietary Name
Covera-hs
Dosage Form
-

Regulatory & Marketing

Labeler Name
Pfizer Laboratories Div Pfizer Inc
FDA Application #
NDA020552
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
02-26-1996
End Marketing Date
07-31-2011
Listing Expiration
07-31-2011
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0025-2011). Click a package code to view its specific billing and regulatory data.

0025-2011-31
100 TABLET, EXTENDED RELEASE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0025-2011-34 identifies a specific commercial package of 100 tablet, extended release in 1 blister pack of Covera-hs, labeled by Pfizer Laboratories Div Pfizer Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pfizer Laboratories Div Pfizer Inc on February 26, 1996. The current certification is valid through July 31, 2011.

How is this Pfizer Laboratories Div Pfizer Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00025201134. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0025-2011-34
11-Digit CMS (5-4-2)
00025-2011-34

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.